Oosterlinck, W., & Decaestecker, K. (2018). An immediate intravesical instillation of mitomycin C is of benefit in all prognostic risk groups with non-muscle-invasive bladder cancers. Transl Androl Urol.
Citação norma ChicagoOosterlinck, Willem, and Karel Decaestecker. "An Immediate Intravesical Instillation of Mitomycin C Is of Benefit in All Prognostic Risk Groups With Non-muscle-invasive Bladder Cancers." Transl Androl Urol 2018.
MLA CitationOosterlinck, Willem, and Karel Decaestecker. "An Immediate Intravesical Instillation of Mitomycin C Is of Benefit in All Prognostic Risk Groups With Non-muscle-invasive Bladder Cancers." Transl Androl Urol 2018.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.